$84.61
Value $4.3B
ECG and GEV stock compared: price, dividend, valuation and results, from SEC filings.
$84.61
Value $4.3B
$764.70
Value $206B
Everus Construction (ECG) has a market value of $4.3B and GE Vernova (GEV) $206B. Over the last year, with dividends, ECG moved -6.2% and GEV +32.4%. The P/E is 14.9 for ECG and 19.9 for GEV. Dividend yield: ECG none, GEV 0.26%.
The main figures of both. A bar only shows which number is larger, not which is better.
Market value
ECG$4.3B
GEV$206B
GEV is 48 times ECG
Revenue, 12 months
ECG$4.7B
GEV$44.0B
GEV is 9.4 times ECG
Net income, 12 months
ECG$289M
GEV$10.4B
GEV is 36 times ECG
Operating margin
ECG8.2%
GEV6.4%
1.8 points apart
ROIC
ECG27.0%
GEV19.5%
7.5 points apart
P/E
ECG14.9
GEV19.9
GEV is 1.3 times ECG
Dividend yield
ECG0.0%
GEV0.3%
0.3 points apart
A fainter bar means a negative number. The 5-year return includes dividends.
Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.
ECG-6.2%
GEV+32.4%
| Period | ECGWith dividends | GEVWith dividends |
|---|---|---|
| 1 year since November 14, 2025 | -6.2%Price -6.2% | +32.4%Price +32.0% |
Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.
As on each company's page. A description, not a recommendation: no one figure says which is better.
ECGEverus ConstructionGEVGE Vernova
| Price | $84.61 | $764.70 |
|---|---|---|
| Market value | $4.3B | $206B |
| Enterprise value (EV) | $4.6B | $192B |
| P/E | 14.9 | 19.9 |
| P/E, 5-year median | – | – |
| P/B | 5.0 | 18.1 |
| EV/EBIT | 12.1 | 68.0 |
| Free cash flow yield | 5.5% | 8.3% |
| Revenue, 12 months | $4.7B | $44.0B |
|---|---|---|
| Net income, 12 months | $289M | $10.4B |
| Free cash flow, 12 months | $237M | $17.1B |
| Earnings per share, 12 months | $5.65 | $38.00 |
| Revenue growth, year on year | 31.5% | 9.0% |
| Revenue growth a year, past | +11.6%over 3 years | +8.7%over 3 years |
| EPS growth a year, past | +17.3%over 3 years | – |
| Gross margin | 13.6% | 21.7% |
|---|---|---|
| Operating margin | 8.2% | 6.4% |
| Net margin | 6.2% | 23.5% |
| ROIC | 27.0% | 19.5% |
| ROE | 41.0% | 90.8% |
| Cash | $264M | $16.8B |
|---|---|---|
| Total debt | $703M | $3.7B |
| Net debt / EBITDA | 0.7 | -4.1 |
| Interest cover | 18.7× | – |
| Dividend yield | – | 0.3% |
|---|---|---|
| Dividend per share, 12 months | – | $2.00 |
| Dividend growth a year, past | – | – |
| Buyback yield | – | 1.6% |
| Shareholder yield | – | 1.9% |
Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.
By market value, GE Vernova ($206B) is about 47.8 times Everus Construction ($4.3B), at today's prices.
Since November 14, 2025, ECG's price moved -6.2% and GEV's +32.0%. With dividends: ECG -6.2% (-6.2% a year), GEV +32.4% (+32.4% a year). Past returns do not predict future ones.
The dividend yield at today's price is none for Everus Construction and 0.26% for GE Vernova. Over the last twelve months they paid – and $2.00 per share.
At today's price, the P/E is 14.9 for ECG and 19.9 for GEV. It is the share price over the last twelve months' earnings per share.
Over the last twelve months, the net margin was 6.2% for Everus Construction and 23.5% for GE Vernova, and the operating margin 8.2% and 6.4%. Revenue was $4.7B and $44.0B.
The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.
With each of the two, and with the largest in its sector.
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
Descriptive data from SEC filings and market prices.